Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 10 May 2021 to 25 May 2021.
Commission On Human Medicines
Latest Government News
- Guidance: River Thames: current river conditions
- Transparency data: Small boat activity in the English Channel
- Press release: 10,000 UK Armed Forces personnel deployed overseas to keep us safe this Christmas
- Guidance: The white book for foreign service advisers and defence attachés
- Guidance: River Thames: current river conditions
- Transparency data: Small boat activity in the English Channel
- Bird flu (avian influenza): latest situation in England
- The Lockerbie bombing
- Guidance: Critical 5 Statement on Security and Resilience
- Consultation outcome: Alcohol licensing: age verification
Monday, 09 December 2024
Monday, 09 December 2024
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 12 April 2021 to 4 May 2021.
Monday, 09 December 2024
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 25 February 2021 to 6 April 2021.
Monday, 09 December 2024
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 13 January 2021 to 15 February 2021.
Monday, 09 December 2024
Meeting minutes taken from meetings of the Vaccine Benefit Risk Expert Working Group (VBREWG) held between 7 December 2020 to 3 January 2021.
Wednesday, 30 October 2024
The appointment will involve a time commitment of 33 days per year. Remuneration for the role will be at a rate of £500 per attendance and preparation for meetings.
Tuesday, 30 July 2024
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission.
Tuesday, 30 July 2024
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission.
Tuesday, 30 July 2024
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission.
Thursday, 08 February 2024
Report of Isotretinoin Implementation Advisory Expert Working Group regarding recommendations to strengthen the safe use of isotretinoin, the acne medicine commonly known by brand names Roaccutane and Reticutan.
Tuesday, 31 October 2023
Report of Isotretinoin Implementation Advisory Expert Working Group regarding recommendations to strengthen the safe use of isotretinoin, the acne medicine commonly known by brand names Roaccutane and Reticutan.
Tuesday, 15 August 2023
The Medicines and Healthcare products Regulatory Agency (MHRA) has undertaken a further review of the safety of albumins manufactured from UK plasma with respect to vCJD.
Wednesday, 19 July 2023
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission.
Wednesday, 26 April 2023
Report of the Commission on Human Medicines (CHM) Isotretinoin Expert Working Group and plain-language summary of the recommendations.
Thursday, 08 September 2022
We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts providing the advice are independent and impartial, and that the processes in place to manage conflicts of interest are robust and clear to all.
Tuesday, 19 July 2022
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Tuesday, 12 April 2022
We are consulting on a set of proposals to improve and strengthen the Code of Practice for experts who provide advice on which decisions about the regulation of medicines and medical devices are based, to ensure that experts providing the advice are independent and impartial, and that the processes in place to manage conflicts of interest are robust and clear to all.
Thursday, 11 November 2021
The chance for adults and children suffering from life-threatening allergic reactions to get life-saving shots of adrenaline in public places, such as restaurants and entertainment venues, has come a step closer as a result of a report published today by the government’s independent advisory body, the Commission on Human Medicines (CHM).
Thursday, 11 November 2021
This report provides a combined summary of the conclusions and recommendations of the Commission on Human Medicines’ Adrenaline Auto-injector Expert Working Group to support the effective and safe use of Adrenaline Auto-injectors.
Thursday, 15 July 2021
Annual Report of the Human Medicines Regulations 2012 Advisory Bodies - the Commission on Human Medicines (CHM) and the British Pharmacopoeia Commission
Friday, 12 February 2021
Professor Sir Munir Pirmohamed has been appointed by the Secretary of State for Health and Social Care as Chair of the Commission on Human Medicines (CHM).
Ministerial Departmental News
- PM's Office, 10 Downing Street
- Cabinet Office
- Department for Business, Innovation and Skills
- Department for Communities and Local Government
- Department for Culture, Media and Sport
- Department for Education
- Department for Environment, Food and Rural Affairs
- Department for International Development
- Department for Transport
- Department for Work and Pensions
- Department of Energy and Climate Change
- Department of Health
- Foreign and Commonwealth Office
- HM Treasury
- Home Office
- Ministry of Defence
- Ministry of Justice
- Northern Ireland Office
- Scotland Office
- Wales Office
- See all departments